The genetics of late-onset Alzheimer's disease

Current Opinion in Neurology

Volumn 14, Issue 4, 2001, Pages 433-440

  Myers, Amanda J ^a   Goate, Alison M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ALZHEIMER DISEASE; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 9; ENVIRONMENTAL FACTOR; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEREDITY; REVIEW; RISK FACTOR;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 9; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PEPTIDE FRAGMENTS; RISK FACTORS;

EID: 0034895326     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200108000-00002     Document Type: Review

References (57)

1. Exploring the etiology of Alzheimer disease using molecular genetics
2. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
3. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
4. Candidate gene for the chromosome 1 familial Alzhelmer's disease locus
5. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
6. Secreted amyloid-β-protein similar to that in senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
7. Unusual phenotypic alteration of β-amyloid precursor protein (βAPP) maturation by a new Val-715→ Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease
8. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice
9. Mutant presenilins of AIzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
10. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
11. Apolipoprotein E isoform-dependant and neuritic degeneration in a mouse model of Alzheimer's disease
12. Apolipoprotein E allele ε4 dementia and cognitive decline in a population
13. APOE genotypes in Australia: Roles in early and late onset Alzheimer's disease and Down's syndrome
14. Apolipoprotein E in Alzhelmer's disease risk and case detection; a case control study
15. Complete genomic screen in late-onset familial Alzheimer's disease
16. Complete genomic screen in late-onset familial Alzheimer's disease: Evidence for a new locus on chromosome 12
17. Identification of novel genes in late-onset Alzheimer's disease
18. A full genome scan for late onset Alzheimer's disease
19. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution
20. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
21. Genetics studies on chromosome 12 in late-onset Alzheimer disease
22. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity
23. Confirmation of linkage results in affected sib-pair linkage analysis for complex genetic traits
24. Replication of linkage studies of complex traits: An examination of variation in location estimates
25. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer disease genetics initiative
26. Allelic association between the D10S1423 marker and Alzheimer's disease in a German population
27. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
28. Susceptibility locus for Alzheimer's disease on chromosome 10
29. Linkage of plasma Aβ 42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
30. Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme
31. Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor
32. Genetic association of the low density lipoprotein receptor-related protein (LRP) gene, an apolipoprotein E receptor, with late onset Alzheimer's disease
33. Genetic association studies between dementia of the Alzheimer type and three receptors for apolipoprotein E in a Caucasian population
34. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies
35. Modulation of amyloid-β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway
36. Is the LDL receptor-related protein involved in Alzheimer's disease?
37. Association between coding variability in the LRP gene and the risk of late onset Alzheimer's disease
38. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics
39. Alpha 2-macroglobulin is genetically associated with Alzheimer disease
40. Alpha 2-macroglobulin gene and Alzheimer's disease: Confirmation of association by haplotype analyses
41. Alpha 2-macroglobulin and the risk of Alzheimer's disease
42. Lack of association of the alpha 2-macroglobulin locus on chromosome 12 in AD
43. The alpha 2-macroglobulin gene in AD: A population-based study and meta-analysis
44. Purification and characterization of the serum amyloid A3 enhancer factor
45. The transcription factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease
46. Apolipoprotein E and Alzheimer's disease; an update of genetic and functional analyses
47. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apolipoprotein E locus
48. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene
49. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
50. Pronounced impact of Th1/E47cs mutation compared with -491AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease
51. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
52. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease
53. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population
54. Apolipoprotein E variation at the sequence haplotype level; implications for the origin and maintenance of a major human polymorphism
55. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease
56. Association of early onset Alzheimer's disease with an interleukin-1 alpha gene polymorphism
57. Association of interleukin-1 gene polymorphisms with Alzheimer's disease